Trial · NCT00909857
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dental caries | Gastrointestinal disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 5 | 234 | 10 |
| other | Dental caries | Gastrointestinal disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 2 | 230 | 7 |
| other | Nausea | Gastrointestinal disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 2 | 234 | 2 |
| other | Nausea | Gastrointestinal disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 5 | 230 | 6 |
| other | Inflammation | General disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 7 | 234 | 7 |
| other | Inflammation | General disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 3 | 230 | 3 |
| other | Influenza | Infections and infestations | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 2 | 234 | 2 |
| other | Influenza | Infections and infestations | Ethinyl Estradiol, Levonorgestrel (Miranova) | 5 | 230 | 5 |
| other | Upper respiratory tract infection | Infections and infestations | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 4 | 234 | 6 |
| other | Upper respiratory tract infection | Infections and infestations | Ethinyl Estradiol, Levonorgestrel (Miranova) | 7 | 230 | 10 |
| other | Headache | Nervous system disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 32 | 234 | 55 |
| other | Headache | Nervous system disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 34 | 230 | 55 |
| other | Tension headache | Nervous system disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 14 | 234 | 40 |
| other | Tension headache | Nervous system disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 9 | 230 | 43 |
| other | Cervical dysplasia | Reproductive system and breast disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 7 | 234 | 7 |
| other | Cervical dysplasia | Reproductive system and breast disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 9 | 230 | 9 |
| other | Dysfunctional uterine bleeding | Reproductive system and breast disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 3 | 234 | 4 |
| other | Dysfunctional uterine bleeding | Reproductive system and breast disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 5 | 230 | 6 |
| other | Dysmenorrhoea | Reproductive system and breast disorders | Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | 87 | 234 | 208 |
| other | Dysmenorrhoea | Reproductive system and breast disorders | Ethinyl Estradiol, Levonorgestrel (Miranova) | 82 | 230 | 210 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00909857/events